Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
BioMarin Pharmaceutical Inc.
Type
Public company
Traded as NASDAQ: BMRN
Industry Biotechnology
Founded 1997
Headquarters San Rafael, CA, USA
Key people
Jean-Jacques Bienaime, Chief Executive Officer
Henry J. Fuchs, Chief Medical Officer
Dan Spiegelman, Chief Financial Officer
Products Kuvan, Naglazyme, Aldurazyme, Firdapse, Vimizim
Revenue Increase US$ 751 million (2014)
Operating income
Decrease US$ -133 million (2014)
Total assets Increase US$ 2.49 billion (2014)
Total equity Increase US$ 1.52 billion (2014)
Number of employees
1681 (2015)
Website www.bmrn.com
Footnotes / references

BioMarin Pharmaceutical Inc. is a biotechnology company based in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin develops and commercializes innovative biopharmaceuticals for serious, life-threatening rare diseases and medical conditions. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin is the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin is also the first company to provide therapeutics for phenylketonuria (PKU).

Investment goal date:
Dividends reinvested
BioMarin Pharmaceutical Inc. BMRN report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-04-30
--
--
Q4 2017
2018-02-21
--
--
Q3 2017
2017-10-26
-0.0700
-0.0700
Q2 2017
2017-08-02
-0.2100
-0.2100
Q1 2017
2017-05-04
-0.0900
-0.0900
Q4 2016
2017-02-23
-0.5300
-0.5300
Q3 2016
2016-10-27
-0.2600
-0.2200
Q2 2016
2016-08-04
-2.6100
-2.5800
Q1 2016
2016-04-28
-0.5300
-0.5100
Q4 2015
2016-02-25
0.3900
0.3900
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BAKER BROS. ADVISORS LP
4806483
Bank of New York Mellon Corp
2279705
BlackRock Fund Advisors
4288652
BlackRock Inc.
11065452
BlackRock Institutional Trust Company, N.A.
4373022
Capital Research Global Investors
19643433
FMR LLC
9703010
Invesco Ltd.
3633198
JENNISON ASSOCIATES LLC
9871207
Palo Alto Investors, LLC
2382619
PRIMECAP MANAGEMENT CO/CA/
8712268
SANDS CAPITAL MANAGEMENT, LLC
8972405
STATE STREET CORP
4001529
TEMASEK HOLDINGS (PRIVATE) LTD
3472712
Vanguard Group, Inc
13702404
Major Shareholders
Name Relationship
Total Shares
Holding stocks
LAPALME PIERRE
0.0200% (30150)
BMRN / INSY /
FUCHS HENRY J
0.0600% (88515)
BMRN / GHDX / MRTX /
LEWIS ALAN
0.0200% (26060)
ASMB / BMRN /
BATE KENNETH
0.0100% (10775)
YOUNG WILLIAM D
0.0100% (10775)
BMRN / TBPH / THRX / VRTX /
BIENAIME JEAN JACQUES
0.1500% (226924)
MEIER RICHARD A
0.0200% (36310)
BMRN / OMI / STAA / TFX /
HERON ELAINE J
0.0300% (39185)
BMRN /
SPIEGELMAN DANIEL K
0.0200% (23303)
GREY MICHAEL G
0.0200% (29810)
BMRN / HZNP / MRTX /
LAWLIS V BRYAN
0.0100% (13360)
BMRN / GERN / KBIO /
BAFFI ROBERT
0.0500% (72102)
BMRN / KBIO /
Davis George Eric
0.0500% (66960)
BMRN /
Mueller Brian
0.0100% (12885)
ANTH / BMRN /
Ajer Jeffrey Robert
0.0300% (48948)
BMRN / NKTR /
% ()